XML 49 R59.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Business Segment Information - Schedule of External Net Sales by SBU Reporting Segment (Detail) (USD $) In Thousands, unless otherwise specified | 3 Months Ended | 9 Months Ended
--- | --- | ---
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013
Sales Information [Line Items] |  |  |  |
Reported Growth (as a percent) | 10.00%ofix_PercentageOfReportedGrowth |  | 3.00%ofix_PercentageOfReportedGrowth |
Constant Currency Growth (as a percent) | 9.00%ofix_PercentageOfConstantCurrencyGrowth |  | 3.00%ofix_PercentageOfConstantCurrencyGrowth |
Net sales | $ 100,994 us-gaap_SalesRevenueNet | $ 91,806 us-gaap_SalesRevenueNet | $ 301,933 us-gaap_SalesRevenueNet | $ 291,725 us-gaap_SalesRevenueNet
BioStim [Member] |  |  |  |
Sales Information [Line Items] |  |  |  |
Reported Growth (as a percent) | 25.00%ofix_PercentageOfReportedGrowth / us-gaap_StatementBusinessSegmentsAxis = ofix_BiostimMember |  | 9.00%ofix_PercentageOfReportedGrowth / us-gaap_StatementBusinessSegmentsAxis = ofix_BiostimMember |
Constant Currency Growth (as a percent) | 25.00%ofix_PercentageOfConstantCurrencyGrowth / us-gaap_StatementBusinessSegmentsAxis = ofix_BiostimMember |  | 9.00%ofix_PercentageOfConstantCurrencyGrowth / us-gaap_StatementBusinessSegmentsAxis = ofix_BiostimMember |
Net sales | 38,285 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = ofix_BiostimMember | 30,654 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = ofix_BiostimMember | 114,937 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = ofix_BiostimMember | 105,828 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = ofix_BiostimMember
Biologics [Member] |  |  |  |
Sales Information [Line Items] |  |  |  |
Reported Growth (as a percent) | 5.00%ofix_PercentageOfReportedGrowth / us-gaap_StatementBusinessSegmentsAxis = ofix_BiologicsMember |  | 2.00%ofix_PercentageOfReportedGrowth / us-gaap_StatementBusinessSegmentsAxis = ofix_BiologicsMember |
Constant Currency Growth (as a percent) | 5.00%ofix_PercentageOfConstantCurrencyGrowth / us-gaap_StatementBusinessSegmentsAxis = ofix_BiologicsMember |  | 2.00%ofix_PercentageOfConstantCurrencyGrowth / us-gaap_StatementBusinessSegmentsAxis = ofix_BiologicsMember |
Net sales | 13,856 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = ofix_BiologicsMember | 13,216 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = ofix_BiologicsMember | 40,718 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = ofix_BiologicsMember | 39,816 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = ofix_BiologicsMember
Extremity Fixation [Member] |  |  |  |
Sales Information [Line Items] |  |  |  |
Reported Growth (as a percent) | 12.00%ofix_PercentageOfReportedGrowth / us-gaap_StatementBusinessSegmentsAxis = ofix_ExtremityFixationMember |  | 11.00%ofix_PercentageOfReportedGrowth / us-gaap_StatementBusinessSegmentsAxis = ofix_ExtremityFixationMember |
Constant Currency Growth (as a percent) | 9.00%ofix_PercentageOfConstantCurrencyGrowth / us-gaap_StatementBusinessSegmentsAxis = ofix_ExtremityFixationMember |  | 9.00%ofix_PercentageOfConstantCurrencyGrowth / us-gaap_StatementBusinessSegmentsAxis = ofix_ExtremityFixationMember |
Net sales | 27,636 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = ofix_ExtremityFixationMember | 24,705 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = ofix_ExtremityFixationMember | 82,005 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = ofix_ExtremityFixationMember | 74,112 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = ofix_ExtremityFixationMember
Spine Fixation [Member] |  |  |  |
Sales Information [Line Items] |  |  |  |
Reported Growth (as a percent) | (9.00%)ofix_PercentageOfReportedGrowth / us-gaap_StatementBusinessSegmentsAxis = ofix_SpineFixationMember |  | (11.00%)ofix_PercentageOfReportedGrowth / us-gaap_StatementBusinessSegmentsAxis = ofix_SpineFixationMember |
Constant Currency Growth (as a percent) | (9.00%)ofix_PercentageOfConstantCurrencyGrowth / us-gaap_StatementBusinessSegmentsAxis = ofix_SpineFixationMember |  | (11.00%)ofix_PercentageOfConstantCurrencyGrowth / us-gaap_StatementBusinessSegmentsAxis = ofix_SpineFixationMember |
Net sales | $ 21,217 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = ofix_SpineFixationMember | $ 23,231 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = ofix_SpineFixationMember | $ 64,333 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = ofix_SpineFixationMember | $ 71,969 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = ofix_SpineFixationMember

X
- Definition Represents the exchange rate that eliminates the effects of exchange rate fluctuations and that is used when calculating financial performance numbers. + References No definition available. + Details
Name: | ofix_PercentageOfConstantCurrencyGrowth
Namespace Prefix: | ofix_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the percentage of growth rate by each segment as reported by the entity. + References No definition available. + Details
Name: | ofix_PercentageOfReportedGrowth
Namespace Prefix: | ofix_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ofix_SalesInformationLineItems
Namespace Prefix: | ofix_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_SalesRevenueNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ofix_BiologicsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ofix_BiostimMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ofix_ExtremityFixationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ofix_SpineFixationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |